Company profile
NuGen Medical Devices Inc.
OTC: NGMDF · Healthcare · Medical - Devices
Canadian filerHQ Toronto, ONReports USD
#1008 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
24DFH 20DQ —GM 38SS 21
v0.1 · 45/100 weight · provisional
↑ 3-yr revenue growth, disclosure history · ↓ listing tenure, revenue growth (YoY)
Methodology →Revenue TTM
$119.6k
Rev growth YoY (TTM)
-84.7%
Net income (FY)
-$5.6M
Employees
5
as of 2026-08-24
Market cap
$2.2M
as of 2026-08-24
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$184.4k257.7k CAD2025
Net income-$5.6M-7.8M CAD2025
Operating income-$3.0M-4.2M CAD2025
Total assets$3.1M4.3M CAD2025
Liabilities$13.1M18.0M CAD2025
Equity-$10.0M-13.7M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is NuGen Medical Devices Inc.’s revenue?
NuGen Medical Devices Inc. booked $184.4k in FY2025 revenue, contracting 75% year over year — slower than 87% of Healthcare companies we track, at a -3034.0% net margin.
Peers · Healthcare
Bioxytran, Inc.27DaTyr Pharma, Inc.36DHemp, Inc——Abpro Holdings, Inc.14DPharmaRoth Labs, Inc.——Panacos Pharmaceuticals, Inc.——Key facts
CEOLin Liang
SectorHealthcare
IndustryMedical - Devices
HeadquartersToronto, ON
ExchangeOTC: NGMDF
Employees5
IPO date2022-02-25
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.